3-(2,2,2-trimethylhydrazine)propionate has been researched along with verapamil in 1 studies
Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
251 | 35 | 105 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böhm, M; Eckel, L; Grube, M; Haney, J; Jedlitschky, G; Kroemer, HK; Meissner, K; Meyer zu Schwabedissen, HE; Möritz, KU; Präger, D; Rosskopf, D | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and verapamil
Article | Year |
---|---|
Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5).
Topics: Aged; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiovascular Agents; Cell Line; Dogs; Endothelial Cells; Female; Genotype; Humans; Male; Methylhydrazines; Middle Aged; Myocardium; Organic Cation Transport Proteins; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA, Messenger; Solute Carrier Family 22 Member 5; Spironolactone; Transfection; Verapamil | 2006 |